Suppr超能文献

肩胛上神经阻滞与关节内皮质类固醇注射治疗粘连性肩关节囊炎的疗效比较:一项随机对照研究。

Is Suprascapular Nerve Block Better Than Intra-articular Corticosteroid Injection for the Treatment of Adhesive Capsulitis of the Shoulder? A Randomized Controlled Study.

机构信息

Macquarie University Hospital, Sydney, Australia.

Assam Medical College, Barbari, Dibrugarh, Assam, India.

出版信息

Ortop Traumatol Rehabil. 2021 Jun 30;23(3):157-165. doi: 10.5604/01.3001.0014.9152.

Abstract

BACKGROUND

Adhesive Capsulitis of shoulder (AdCS) is a treatment dilemma for surgeons. Intraarticular Corticosteroid Injection (IACI) has shown only short-term benefit in improving shoulder-related disability. Suprascapular nerve block (SSNB) has shown promise in trials in reducing chronic shoulder pain. Thus a RCT was conducted to compare the efficacy of SSNB versus IACI in the treatment of AdCS.

MATERIAL AND METHODS

86 patients with AdCS were divided into SSNB and IACI groups by block randomization. SSNB group received single Suprascapular Nerve Block with 10ml of 0.5% Bupivacaine while IACI group received single injection of 40mg Triamcinolone and 1ml 2% Lignocaine in the shoulder; both followed by physiotherapy and followed-up and evaluated with SPADI and modified Constant scores at 1, 6 and 12 weeks.

RESULTS

Statistically significant improvements occurred in both groups. At 12 weeks, the SPADI and Con-stant score for SSNB improved to 9.62±10.07 and 36.95±3.43 respectively (p<0.001); and for IACI improved to 11.65±5.56 and 35.07±3.32 respectively (p <0.001). The difference in the scores between the 2 groups at 1st and 6th week was insignificant, but was statistically significant in favour of SSNB at 12 weeks (p=0.002).

CONCLUSIONS

  1. Thus, from the present study it can be concluded that both Suprascapular Nerve Block and Intra-articular Corticosteroid injection are effective mo-dalities of treatment for Adhesive Capsulitis of the shoulder. 2. Suprascapular Nerve Block increased patients' pain tolerability for effective mobilization, the effect be-ing persistent even at 12 weeks following injection. 3. It was safer than Intra-articular Corticosteroid in-jection with less incidence of adverse effects in our study and the literature. 4. It is an easy-to-perform outpatient procedure, with minimal chance of infection and other complications. 5. In light of the above, we may recommend Su-prascapular Nerve Block as the initial procedure of choice in patients with Adhesive Capsulitis of Shoulder.
摘要

背景

肩粘连性囊炎(AdCS)是外科医生面临的治疗难题。关节内皮质类固醇注射(IACI)已显示出在改善与肩部相关的残疾方面仅具有短期益处。肩胛上神经阻滞(SSNB)在临床试验中已显示出减少慢性肩部疼痛的潜力。因此,进行了一项 RCT,以比较 SSNB 与 IACI 在治疗 AdCS 中的疗效。

材料和方法

将 86 例 AdCS 患者按块随机分为 SSNB 和 IACI 组。SSNB 组接受单次肩胛上神经阻滞,用 0.5%布比卡因 10ml;IACI 组在肩部接受单次注射 40mg 曲安奈德和 1ml 2%利多卡因;两组均接受物理治疗并随访,在 1、6 和 12 周时分别用 SPADI 和改良 Constant 评分进行评估。

结果

两组均有显著改善。在 12 周时,SSNB 的 SPADI 和 Constant 评分分别改善至 9.62±10.07 和 36.95±3.43(p<0.001);IACI 分别改善至 11.65±5.56 和 35.07±3.32(p<0.001)。第 1 周和第 6 周两组评分差异无统计学意义,但第 12 周时 SSNB 有统计学意义(p=0.002)。

结论

  1. 因此,从本研究可以得出结论,肩胛上神经阻滞和关节内皮质类固醇注射都是治疗肩粘连性囊炎的有效方法。2. 肩胛上神经阻滞增加了患者对有效活动的疼痛耐受性,即使在注射后 12 周,效果仍然持续。3. 与关节内皮质类固醇注射相比,本研究和文献中的不良反应发生率更低,安全性更高。4. 它是一种易于进行的门诊程序,感染和其他并发症的机会最小。5. 鉴于上述情况,我们可能会建议将肩胛上神经阻滞作为肩粘连性囊炎患者的首选初始治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验